# Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?

> **NCT06592716** · — · ACTIVE_NOT_RECRUITING · sponsor: **Rigshospitalet, Denmark** · enrollment: 200 (estimated)

## Conditions studied

- Oropharynx Cancer
- Oropharynx Cancer, Metastatic
- Oropharynx Cancer, Recurrent
- Oropharyngeal Carcinoma
- Oropharyngeal Squamous Cell Carcinoma (OPSCC)

## Interventions

- **DIAGNOSTIC_TEST:** Liquid biopsy

## Key facts

- **NCT ID:** NCT06592716
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-04-02
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06592716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06592716, "Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06592716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*